BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15507947)

  • 1. Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop.
    McKeeman GC; Ardill JE; Caldwell CM; Hunter AJ; McClure N
    Am J Obstet Gynecol; 2004 Oct; 191(4):1240-6. PubMed ID: 15507947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.
    Rajakumar A; Michael HM; Rajakumar PA; Shibata E; Hubel CA; Karumanchi SA; Thadhani R; Wolf M; Harger G; Markovic N
    Placenta; 2005 Aug; 26(7):563-73. PubMed ID: 15993706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble vascular endothelial growth factor receptor-1 (sFLT-1) mediates downregulation of FLT-1 and prevents activated neutrophils from women with preeclampsia from additional migration by VEGF.
    Krysiak O; Bretschneider A; Zhong E; Webb J; Hopp H; Verlohren S; Fuhr N; Lanowska M; Nonnenmacher A; Vetter R; Jankowski J; Paul M; Schönfelder G
    Circ Res; 2005 Dec; 97(12):1253-61. PubMed ID: 16269656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Predictive value of serum soluble fms-like tyrosine kinase 1 concentration in preeclampsia at second trimester].
    Ye YH; Liu L; Zhan Y; Peng W
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):433-5. PubMed ID: 17083803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alteration and potential role of soluble fms-like tyrosine kinase receptor 1 in preeclampsia].
    Li Y; Li DH; Yao YQ; Min BH; Zhang CL; Hou XH; Huang L; Zhao HX
    Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):581-4. PubMed ID: 16202309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum sFlt-1/Ang-2 ratio in women with preeclampsia.
    Hirokoshi K; Maeshima Y; Kobayashi K; Matsuura E; Sugiyama H; Yamasaki Y; Masuyama H; Hiramatsu Y; Makino H
    Nephron Clin Pract; 2007; 106(1):c43-50. PubMed ID: 17409768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.
    Park CW; Park JS; Shim SS; Jun JK; Yoon BH; Romero R
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):984-9. PubMed ID: 16157098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression and significance of soluble fms-like tyrosine kinase 1 in preeclampsia placenta].
    Ye YH; Liu L; Zhan Y; Peng W
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):521-4. PubMed ID: 17083834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma markers of angiogenesis in pregnancy induced hypertension.
    Nadar SK; Karalis I; Al Yemeni E; Blann AD; Lip GY
    Thromb Haemost; 2005 Nov; 94(5):1071-6. PubMed ID: 16363251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of hypoxia-inducible factor-1alpha, vascular endothelial growth factor and sFlt-1 in preeclampsia placenta].
    Sun SG; Shen N; Zheng YH; Shang T
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):440-4. PubMed ID: 17083805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Predictive value of soluble vascular endothelial growth factor receptor 1 for preeclampsia in second-trimester].
    Chen Q; Zhao Y; Zou L; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):161-4. PubMed ID: 17537299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia.
    Buhimschi CS; Norwitz ER; Funai E; Richman S; Guller S; Lockwood CJ; Buhimschi IA
    Am J Obstet Gynecol; 2005 Mar; 192(3):734-41. PubMed ID: 15746665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The levels of circulating vascular endothelial growth factor and soluble Flt-1 in pregnancies complicated by preeclampsia.
    Lee ES; Oh MJ; Jung JW; Lim JE; Seol HJ; Lee KJ; Kim HJ
    J Korean Med Sci; 2007 Feb; 22(1):94-8. PubMed ID: 17297258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance.
    Bosio PM; Wheeler T; Anthony F; Conroy R; O'herlihy C; McKenna P
    Am J Obstet Gynecol; 2001 Jan; 184(2):146-52. PubMed ID: 11174494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia.
    Baker PN; Krasnow J; Roberts JM; Yeo KT
    Obstet Gynecol; 1995 Nov; 86(5):815-21. PubMed ID: 7566855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia.
    Chaiworapongsa T; Romero R; Kim YM; Kim GJ; Kim MR; Espinoza J; Bujold E; Gonçalves L; Gomez R; Edwin S; Mazor M
    J Matern Fetal Neonatal Med; 2005 Jan; 17(1):3-18. PubMed ID: 15804781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between urinary albumin and serum soluble fms-like tyrosine kinase 1 (sFlt-1) in normal pregnancy.
    Yoshimatsu J; Matsumoto H; Goto K; Shimano M; Narahara H; Miyakawa I
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):204-8. PubMed ID: 16426725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia.
    Powers RW; Roberts JM; Cooper KM; Gallaher MJ; Frank MP; Harger GF; Ness RB
    Am J Obstet Gynecol; 2005 Jul; 193(1):185-91. PubMed ID: 16021077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award.
    Chaiworapongsa T; Romero R; Espinoza J; Bujold E; Mee Kim Y; Gonçalves LF; Gomez R; Edwin S
    Am J Obstet Gynecol; 2004 Jun; 190(6):1541-7; discussion 1547-50. PubMed ID: 15284729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia.
    Garovic VD; Wagner SJ; Petrovic LM; Gray CE; Hall P; Sugimoto H; Kalluri R; Grande JP
    Nephrol Dial Transplant; 2007 Apr; 22(4):1136-43. PubMed ID: 17255128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.